Bijoy Hans Limited has successfully completed a major preferential allotment and strategic acquisition program, significantly expanding its corporate structure through share swap arrangements. The company's board meeting held on March 04, 2026, approved the allotment of 4,05,21,836 equity shares and the acquisition of three subsidiaries.

Strategic Acquisitions Through Share Swap

The company executed three separate acquisition transactions, each structured as share swap arrangements where equity shares were allotted in exchange for acquiring target companies:

All equity shares were issued at Rs. 12.50 per share, including a premium of Rs. 2.50 per share, with a face value of Rs. 10.00 each. The transactions were conducted on a preferential allotment basis through private placement to the respective shareholders of the target companies.

Capital Structure Transformation

The preferential allotment resulted in a dramatic expansion of the company's equity capital structure:

The newly allotted equity shares will rank pari-passu with existing equity shares and will be subject to lock-in provisions as per SEBI regulations. The company plans to apply for listing and trading approval for the newly allotted shares.

Allottee Distribution and Compliance

The preferential allotment involved 191 investors, with the majority being non-promoter entities and individuals. The largest single allotment went to SMCV Management Services Private Limited (promoter category) with 99,98,879 shares, while Arogya Tech Services LLP received 32,77,460 shares as a non-promoter allottee.

Promoter Reclassification Initiative

The board also approved a significant governance change by accepting reclassification requests from four promoter group members:

This reclassification from 'promoter and promoter group' category to 'public' category is subject to approval from stock exchanges where the company's shares are listed, in accordance with Regulation 31A of SEBI Listing Regulations.

Regulatory Approvals and Timeline

The preferential allotment received in-principle approval from BSE Limited through letter no. LOD/PREF/TT/FIP/1722/2025-26 dated February 17, 2026. The process followed approvals granted at the Board Meeting held on November 04, 2025, and subsequent shareholder approval at the Extraordinary General Meeting on November 28, 2025. The board meeting on March 04, 2026, commenced at 3:00 p.m. and concluded at 5:00 p.m., finalizing all transaction approvals and allotments.

Bijoy Hans Limited successfully conducted its Extraordinary General Meeting (EGM) on February 25, 2026, securing unanimous shareholder approval for two critical corporate resolutions. The company submitted the voting results and scrutinizer's report to BSE Limited and The Calcutta Stock Exchange Limited on February 26, 2026, fulfilling regulatory obligations under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Overview and Participation

The EGM was conducted through video conferencing from 03:05 PM to 03:29 PM on February 25, 2026. Out of 3218 total shareholders on the record date of February 18, 2026, the meeting saw participation from 22 shareholders through video conferencing - 3 from the promoter group and 19 from the public category.

Voting Results and Resolutions

Both special resolutions presented at the EGM received overwhelming support from shareholders. The voting process was conducted through e-voting, with Mr. Chinmay Mohan Lele (Membership Number: 12351) serving as the appointed scrutinizer.

Resolution 1: Company Name Change

The first resolution sought approval for changing the company name from "Bijoy Hans Limited" to "Arvaya Healthtech Limited." This strategic rebranding received unanimous approval from all voting shareholders.

Resolution 2: Director Appointment

The second resolution regularized the appointment of CA Manali Aditya Pandit (DIN: 11495478) as an Independent Director. This governance-related resolution also secured complete shareholder backing.

Regulatory Compliance and Documentation

The company demonstrated strong corporate governance by ensuring full compliance with statutory requirements. Company Secretary Guinea Agrawal submitted comprehensive documentation to stock exchanges, including detailed voting results and the scrutinizer's report prepared by Mr. Chinmay Mohan Lele.

The e-voting process was conducted through National Securities Depository Limited (NSDL) platform, allowing shareholders to vote remotely from February 22-24, 2026, and during the EGM itself. The scrutinizer confirmed that all voting procedures were conducted fairly and transparently, with proper maintenance of electronic registers recording shareholder participation.

Strategic Implications

The approved name change to "Arvaya Healthtech Limited" signals the company's strategic pivot toward the healthcare technology sector. This rebranding initiative, combined with the strengthening of board composition through the independent director appointment, positions the company for its evolving business focus. The unanimous shareholder support demonstrates strong confidence in management's strategic direction and governance initiatives.